This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Codexis Selected For Third Presidential Green Chemistry Award In Seven Years

Codexis, Inc. (Nasdaq:CDXS) today announced it has been awarded the annual Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) for the development of an efficient biocatalytic process to manufacture simvastatin, a leading drug for treating high cholesterol. This marks the third time in seven years that Codexis has been honored with this award; Codexis was a recipient in 2006 and 2010.

Simvastatin is the most prescribed statin in the U.S., with 94.1 million prescriptions in 2010 according to IMS Health. Traditionally, synthesis of simvastatin has required an inefficient, multistep chemical process that involves significant quantities of hazardous reagents. In collaboration with Professor Yi Tang at the University of California, Los Angeles, Codexis conceived and developed a synthesis using an engineered enzyme and a practical, low-cost feedstock. Codexis optimized both the enzyme and the chemical process for the large-scale, commercial manufacture of simvastatin. The resulting process produces high quality simvastatin in a cost–effective manner and greatly reduces the use of hazardous chemicals and the amount of waste produced.

“Collaborating with the Codexis team was a true inspiration. Their directed evolution technology empowered us to go beyond academic theory and deliver a more environmentally friendly process that is impacting the pharmaceutical industry today,” said Yi Tang, Professor, University of California Los Angeles.

“Green chemistry and Codexis’ CodeEvolver™ directed evolution technology represent the future of cleaner, more efficient, and cost-advantaged pharmaceutical manufacturing processes. With the help of Professor Tang and his team, this award confirms Codexis’ role as an industry leader, and we are honored to be recognized for a third time by the EPA for our achievements,” said Gjalt Huisman, Ph.D., Vice President of Product Planning, Pharmaceuticals at Codexis.

The process was scaled up at Codexis’ longstanding collaborator, Arch Pharmalabs Ltd., in Mumbai, India. Arch Pharmalabs manufactures a number of products for Codexis, including the 2006 Presidential Green Chemistry Challenge Award-winning process for atorvastatin, the active ingredient in Pfizer’s Lipitor ®.

“We are running six biocatalytic processes developed by Codexis and have shown that they are reliably scalable and comparable to chemical processes, while offering significant advantages in terms of product purity, reduced waste, and reduced energy consumption,” said Dr. Ganesh Pai, Director of Research and Development, Arch Pharmalabs Ltd.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.11 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs